TrialLiver international : official journal of the International Association for the Study of the Liver2025

A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis.

Javier Armisen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.